Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
Sign Up to like & getrecommendations! Published in 2019 at "Pharmaceutical Research"
DOI: 10.1007/s11095-019-2577-8
Abstract: In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused… read more here.
Keywords: drug development; focused drug; ophthalmology; drug ... See more keywords
Building on the successes of patient-focused drug development: a call for new policies to maintain momentum
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2024.1416123
Abstract: Since its commencement as part of the Food and Drug Administration’s (FDA) Prescription Drug User Fee Act (PDUFA) V in 2012, patient-focused drug development (PFDD) has become an integral part of the drug development paradigm.… read more here.
Keywords: focused drug; drug development; new policies; drug ... See more keywords